Review on Probiotics as A Health Supplement

Probiotics were first proposed in 1908 by “Nobel Prize winner Eli Metchnikoff”, who hypothesized that the long lives of Bulgarian peasants were due to their eating foods made from fermented milk. Stillwell and Lilly used the word "probiotic" first in the year of 1965 to highlight the chemicals produced by one microbes that promote the another microbial growth. “Marteau et al.” highlited them as "microbial preparations or components of microbial cells that have a beneficial effect on health and well-being" in 2002. [2][5] Numerous microorganisms that are present in skin, mouth, GI trace & various part of the body. The GI tract, with surface area of more than 400 m2, it contains of commensal microbes highest in our body. More than 500 distinct bacterial species are found in the rich flora of the gastrointestinal tract (GIT), some of them have good health benefits like boosting immunity, protecting the person from invasive harmful microbs. The gut microbiota is captured quickly after born, stays mostly constant throughout our lifetime, and it is critical to maintaining homeostasis of human. An individual and distinct intestinal immune system evolves as a result of interactions between developing the host   and intestinal microbiota. The task of the mucosal system immune of host is to seperate between infections and benign species by inducing protective immunity and avoiding the inflammatory action which can disbalance the intrigity of git mucosa.[12][5]

1.2. Definition of Probiotics:

Live microorganisms known as probiotics can be added to a wide range of goods, such as medications, food products, and dietary supplements. The term "probiotic" refers to a relatively recent concept—that of microorganisms that have positive effects on both humans and animals. [1][6] An Expert Group described probiotics as "live microorganisms which upon ingestion in certain numbers exert health benefits beyond inherent general nutrition." The name probiotic means "for life." [4]. The FAO/WHO Expert Consultation is of the opinion that broad recommendations regarding the testing and validation of these microorganisms' safety and possible health benefits for human administration are necessary.  The two probiotics that are most frequently utilized in food and feed are Lactobacillus and Bifidobacterium. Probiotics also include other bacteria such as Bacillus species, some Escherichia coli strains, and yeast Saccharomyces cerevisiae. Since ancient times, lactic acid bacteria (LAB), which are used to ferment food, have been employed for both purposes. [14] LAB can ferment food and may also have health advantages. According to reports, LABs are GRAS (generally acknowledged as safe) and do not possess any pathogenic or virulence characteristics. Certain desirable properties, like low cost, ability to maintain viability throughout processing and storage, ease of application in goods, and resistance to physical and chemical processing, should be taken into consideration for the use of LAB as probiotics. [18]

2.1. Good & Bad Microbes:

Numerous microorganisms in our body cooperate to carry out various tasks. Which can found in our GIT track are the mostly. They enhance the ingestion and digestion of food. They can fullfil a lot of the corns in our digestion. Alternatively, a variety of pathogenic varieties of various microorganisms will take over and misdigest our food. In the course of breaking down our meal, they will even add certain toxins to it. As a result, our health will really deteriorate with each dietary cycle (Amara, 2012). Many illnesses are ignored and not diagnosed when, in reality, their main primary reason is the presence of harmful bacteria in the digestive tract. This is mostly because of leakage from eating procedures, lifestyle c, or even sickness of themselves, which increase the scales in favour of harmful bad bacteria. [10][3]

2. Microbial Species as Probiotics:

Gaining more knowledge into the makeup and traits of the gut microbiota—a microbial ecosystem—is the aim of contemporary probiotic research. It is crucial to remember that each strain of probiotic has a different impact. Since bacterial strains can differ widely in their probiotic activity even within a species, every probiotic strain has a distinct health claim. Because of this, describing each probiotic's distinct qualities requires mentioning the strain.
To achieve this, molecular methods like as pulsed-field gel electrophoresis for strain typing, 16S RNA sequencing, and DNA-DNA hybridization might be used to genetic identification. Rapid quantitative and qualitative insights into the gut microbiome's composition may be obtained by the polymerase chain reaction (PCR) approach. [8] Furthermore, a variety of probiotic pills are said to include several strains. The advantages of utilizing a single strain alone or in combination might differ. Everybody has a different combination of gut bacteria that are involved in certain functions, such immunomodulation, gut mucosal barrier maintenance, and nutrition metabolism. Though the phrase "probiotics" may also apply to other types of bacteria, including Streptococcus, Enterococcus, Saccharomyces (a yeast strain), and Bacillus, it is most often linked with the common strains of Bifidobacterium and Lactobacillus. Numerous probiotic strains have been selected based on predetermined parameters. Certain bacteria that do not usually colonize the gastrointestinal tract, such Lactobacillus bulgaricus, streptococcus thermophilus, and Leonostoc species, may also be classified as probiotics. The gut's microbial balance is not significantly impacted by these bacteria's colonization or activity there. They do, nonetheless, profoundly impact the food sector. To find new strains and the future kind that may be probiotics, a lot of research is being done. Before being put into use, these new strains need to be assessed and scrutinized using established and verified selection standards. [12] [15]

2.3. Requisites for Selection of Safe and Effective Probiotics:

The scientific definition of probiotics and the criteria approving their appropriate use were developed eighteen years earlier. The goal of delivering live microorganisms is to help the therapeutic function take primacy. The majority of probiotics are marketed as foods or medications (tablets, powders, and other formulations) that include living microorganisms. There is a large range of dietary items that can accommodate probiotic strains, including yogurt, cheese, ice cream, buttermilk, powdered milk, and fermented milk. Given that probiotics are undoubtedly extremely sensitive to a variety of environmental stresses, including heat, oxygen, acidity, and other conditions, their viability and feasibility are essential considerations when creating probiotic-based foods. [13] [16] The market for probiotic food products is expanding globally as a result of the constant stream of studies that show their potential health advantages for consumers. Because commonly utilised bacteria are frequently isolated from clinical infection sites, probiotic safety and product compatibility with microorganisms are critical considerations. Their safety and infectiousness have come under scrutiny as a result. Nevertheless, since their separation is the consequence of opportunistic infection—which might be brought on by cancer, skin injuries, chronic illnesses, or drug-induced abnormalities—it is doubtful that they require generalised infectivity. In actuality, Bifidobacterium and Lactobacillus seldom cause infections in people. This lack of virulence extends to immunocompromised individuals as well as all age groups. [11] It is not an easy undertaking to evaluate the safety of probiotics from many perspectives. For an in vitro investigation of multiple components, it is, nevertheless, rather simple. Numerous studies involving both humans and animals have been proposed to evaluate the safety standards of probiotics by examining the strain's intrinsic properties, its pharmacokinetics (i.e., survival, intestinal activity, faecal and mucosal recovery), and the interaction between the strain and host. However, there is disagreement about these parameters' values because operating practices are not standardised. Therefore, studies that are tailored to a target audience and their role should be the best course of action. While many probiotic strains are widely regarded as risk-free, safe, and seldom have adverse host effects reported, it is still necessary to consider the following considerations when evaluating a probiotic's safety and efficacy: [13] [18]

• Genetically identified at the strain, species, and genus levels (whole genome strain characterization)
• Not infectious or pathogenic.
• The gene for transferable antibiotic resistance shouldn't be present.
• Non-toxic [no hazardous materials such as amines, ammonia, indole, or phenol are formed]
• Capable of surviving in sufficient numbers throughout intestinal transit [tolerant of bile and acid] [111]
• Bile salt hydrolase activity [prevents carcinogenesis by deconjugating biliary salt].
• Antimicrobial action [ability to colonise, stick to the mucosal epithelium, and drive out pathogens through competitive exclusion]
• Capable of provoking pathogenic bacteria [the study conducted in vitro is dependent on the mass of microbial cells, the buffer component, the duration of fermentation, and the growth medium] [9]
• Stable and able to survive in storage conditions [increases immunomodulation, increases gut adhesion, and decreases gut permeability]
• Clinically proven and verified health impacts [that require testing in a human randomised controlled study.
• Specified strain intended for usage with humans and animals.

Aside from that, there are a few more factors that need to be discussed in the safety analysis, including the activity of platelets aggregating and the activity of mucus degrading. Different strains of L. Rhamnosus, which have more activity than laboratory strains, were isolated by Harry et al. from infective endocarditis. This implies that they might have an infectious characteristic that aids in the development of endocarditis. The generation of the enzymes glycosidase and protease is responsible for mucous degradation activity. These enzymes have the potential to break down intestinal mucous glycoproteins, leading to infectious endocarditis. The effectiveness of this suggested mechanism was not discovered by Ruserler et al. in their investigation of lactobacillus and bifidobacterium. As a result, determining the infectivity associated with the glycoprotein and lectin-containing outer layer structure is crucial. [13] [15]

MECHANISM OF ACTION:

Uncertainty surrounds the methods by which probiotics produce their positive benefits. However, many of their positive effects may be linked to a number of hypothesized processes. One of these approaches is the competition between probiotics for cell attachments, or adhesion sites. Several pathogenic organisms must establish a link with the GI tract epithelium in order to invade the body. But some strains of bifidobacterial and lactobacilli may stick to epithelium, functioning as "colonization barriers" to prevent pathogens from adhering to mucosa. "To demonstrate this effect, Lactobacillus plantarum 299v and Lactobacillus rhamnosus strain GG were used." These two microorganisms exhibited E. Coli's potential to stick to human colon cells. Another mode of action is the creation of antimicrobial chemicals, which may modify the microbial flora. Numerous "lactobacilli" and "bifidobacteria" species create bacteriocinsor and other antibacterial substances. Bacteriocins may be characterized as "compounds produced by bacteria that have a biologically active protein moiety and a bactericidal action". Other physiologically active chemicals that lactic acid bacteria may generate include diacetyl, hydrogen peroxide, and short-chain fatty acids. The chemical is released secreted by probiotic bacteria, which alters the microbiota in a beneficial manner. [13] [16] Certain species of lactobacilli and bifidobacteria do not release chemicals with antimicrobial characteristics, while others do have very nonspecific actions that may be damaging to both pathogenic and benign bacteria. Probiotics have been demonstrated to enhance immunity as well. Increased natural killer cell counts, increased macrophage phagocytic activity, or increased immunoglobulin-A (IgA) synthesis are some examples of how the immune system mayrespond. Increased IgA production may enhance the composition of the microflora by reducing the amount of harmful bacteria in the gut. Because of their immunomodulatory features, probiotics have been connected to possible therapy advantages for a variety of disorders, such as urogenital infections, food allergies, pouchitis, and inflammatory bowel disease (IBD), in addition to functioning as a vaccination booster. It is likely that probiotics will compete with pathogens for nutrients. This topic involves Clostridium difficile, a potentially hazardous bacteria that feeds on monosaccharides. Probiotics may eat most of the available monosaccharides when there are plenty of them, which inhibits C. difficile from developing.